Novo Nordisk A/S secures FDA nod for oral Wegovy, expanding obesity treatment options. Click for how oral GLP-1 therapies ...

Here's when you can get the FDA-approved, daily pill version of Novo Nordisk's wildly popular GLP-1 drug Wegovy.

The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back.

As Novo Nordisk’s weight-loss pill Wegovy (semaglutide) readies for a launch in the United States early January, it will be a ...

The drugs' high prices, along with spotty insurance coverage, have left them out of reach for many Americans. Read more at ...

The grocery giant's plans call for minor interior renovations this spring at three stores in San Antonio, Seguin and Boerne ...

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

Schumer apologises in December 2025, calling on celebs to come clean about weight-loss medication and surgery, but some ...

Hyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming ...

The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...

In a significant development for global health, U.S. regulators have approved an oral version of the Wegovy weight-loss drug, marking the first time this powerful treatment will be available in pill ...

A new study uses shopping receipts to show how appetite changes from Ozempic and Wegovy affect grocery and restaurant ...